================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) February 23, 2004
Kewaunee Scientific Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-5286 38-0715562
---------------------------- ---------------- -------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
2700 West Front Street
Statesville, North Carolina 28677
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 704-873-7202
N/A
--------------------------------------------------------------------------------
(Former name or former address if changed since last report)
================================================================================
Item 7. Financial Statements and Exhibits
(c) Exhibits.
Exhibit No. Subject Matter
----------- --------------
99.1 Press Release dated February 23, 2004, of Kewaunee Scientific
Corporation, announcing its third quarter earnings.
Item 12. Results of Operations and Financial Condition.
On February 23, 2004 Kewaunee Scientific Corporation (the
"Company") issued a Press Release announcing its third quarter
earnings. The Press Release is incorporated herein by
reference, and is included as Exhibit 99.1 to this Current
Report on Form 8-K.
Exhibit 99.1 to this report contains information regarding
certain non-recurring items incurred by the Company. For
comparative purposes, following the disclosure of certain
financial measures in Exhibit 99.1 that include the applicable
non-recurring items, the Company has reported the impact on
net earnings resulting from the non-recurring items, which
additional information constituting a "non-GAAP financial
measure" as defined in Item 10 of Regulation S-K of the
Securities Exchange Act of 1934, as amended. The Company has
included this additional information because it believes that
the disclosure of such information facilitates the comparison
of the Company's current results of operations to prior
periods.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
(Registrant)
Kewaunee Scientific Corporation
Date: February 23, 2004 By: /s/ D. Michael Parker
--------------------------------
Senior Vice President, Finance
Chief Financial Officer
3